| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 650007 | 48827 | DEPAKINE 200 mg COMPRIMIDOS GASTRORRESISTENTES | DEPAKINE 200 mg COMPRIMIDOS GASTRORRESISTENTES , 100 comprimidos | 200 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/48827/48827_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/48827/48827_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 40842 | SANOFI AVENTIS S.A. | 1970-01-01 | 1 | 1 | 1 | 1970-01-01 | 2004-10-01 | 0 | 2011-06-09 | 945840, 682872, 671099 | View Edit Delete | |||||||||||
| 650221 | 98085012 | KARVEZIDE 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KARVEZIDE 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 150 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98085012/98085012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98085012/98085012_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2004-10-01 | 1 | 1 | 1 | 2004-10-01 | 2004-10-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 650222 | 98085017 | KARVEZIDE 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | KARVEZIDE 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 300 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98085017/98085017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98085017/98085017_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2004-10-01 | 1 | 1 | 1 | 2004-10-01 | 2004-10-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 650915 | 66650 | REMINYL 8 CAPSULAS DURAS DE LIBERACION PROLONGADA | REMINYL 8 CAPSULAS DURAS DE LIBERACION PROLONGADA , 28 cápsulas | 8 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66650/66650_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66650/66650_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42416 | ESSENTIAL PHARMA LIMITED | 2005-03-07 | 1 | 1 | 1 | 2005-03-07 | 2005-03-07 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 650916 | 66651 | REMINYL 16 mg CAPSULAS DURAS DE LIBERACION PROLONGADA | REMINYL 16 mg CAPSULAS DURAS DE LIBERACION PROLONGADA , 28 cápsulas | 16 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66651/66651_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66651/66651_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42416 | ESSENTIAL PHARMA LIMITED | 2005-03-03 | 1 | 1 | 1 | 2005-03-03 | 2005-03-03 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 650917 | 66652 | REMINYL 24 mg CAPSULAS DURAS DE LIBERACION PROLONGADA | REMINYL 24 mg CAPSULAS DURAS DE LIBERACION PROLONGADA , 28 cápsulas | 24 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66652/66652_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66652/66652_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 42416 | ESSENTIAL PHARMA LIMITED | 2005-03-03 | 1 | 1 | 1 | 2005-03-03 | 2005-03-03 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 650155 | 66338 | DOXAZOSINA NEO TEVA-RATIOPHARM 4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | DOXAZOSINA NEO TEVA-RATIOPHARM 4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66338/66338_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66338/66338_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-09-16 | 1 | 1 | 1 | 2004-09-17 | 2004-09-16 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 650273 | 63961 | LISINOPRIL TEVA-RATIOPHARM 5 mg COMPRIMIDOS EFG | LISINOPRIL TEVA-RATIOPHARM 5 mg COMPRIMIDOS EFG, 60 comprimidos | 5 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63961/63961_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63961/63961_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2001-06-06 | 1 | 1 | 1 | 2001-06-06 | 2004-09-29 | 1 | 2011-10-07 | 867580 | View Edit Delete | |||||||||||
| 650472 | 66482 | CITALOPRAM TEVA-RATIOPHARM 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CITALOPRAM TEVA-RATIOPHARM 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66482/66482_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66482/66482_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-11-22 | 1 | 1 | 1 | 2004-11-22 | 2004-11-22 | 1 | 2011-06-08 | View Edit Delete | ||||||||||||
| 650539 | 66508 | CITALOPRAM TEVA-RIMAFAR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | CITALOPRAM TEVA-RIMAFAR 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 56 comprimidos | 20 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66508/66508_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66508/66508_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-12-21 | 1 | 1 | 1 | 2004-12-21 | 2004-12-21 | 1 | 2017-05-10 | View Edit Delete | ||||||||||||
| 650562 | 66530 | LORATADINA TEVA-RATIOPHARM 10 mg COMPRIMIDOS EFG | LORATADINA TEVA-RATIOPHARM 10 mg COMPRIMIDOS EFG, 20 comprimidos | 10 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66530/66530_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66530/66530_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2005-01-19 | 1 | 1 | 1 | 2005-01-19 | 2005-01-19 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 651028 | 66069 | SERTRALINA TEVA-RATIO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TEVA-RATIO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 100 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66069/66069_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66069/66069_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-05-07 | 1 | 1 | 1 | 2004-05-07 | 2005-04-08 | 1 | 2019-12-14 | View Edit Delete | ||||||||||||
| 651029 | 66070 | SERTRALINA TEVA-RATIO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SERTRALINA TEVA-RATIO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66070/66070_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66070/66070_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2004-05-07 | 1 | 1 | 1 | 2004-05-07 | 2005-04-08 | 1 | 2020-05-14 | View Edit Delete | ||||||||||||
| 651152 | 04304004 | AZILECT 1 MG COMPRIMIDOS | AZILECT 1 MG COMPRIMIDOS, 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04304004/04304004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04304004/04304004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2005-06-16 | 1 | 1 | 1 | 2005-06-16 | 2005-06-16 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 627802 | 54634 | HEMOVAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA | HEMOVAS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA , 500 comprimidos | 400 mg | 6 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/54634/54634_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/54634/54634_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | FERRER INTERNACIONAL S.A. | 1979-03-01 | 1 | 1 | 1 | 1979-03-01 | 1979-03-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 650822 | 66613 | PROSPANTUS JARABE | PROSPANTUS JARABE , 1 frasco de 100 ml | 7 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66613/66613_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66613/66613_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5323 | FERRER INTERNACIONAL S.A. | 2005-02-10 | 1 | 1 | 1 | 2005-02-10 | 2005-02-10 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 650500 | 53004 | ESBERIVEN 100 mg/ml SOLUCION ORAL | ESBERIVEN 100 mg/ml SOLUCION ORAL, 1 frasco de 200 ml | 100 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/53004/53004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/53004/53004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41329 | FAES FARMA S.A. | 1975-04-01 | 1 | 1 | 1 | 1975-04-01 | 2004-12-09 | 1 | 2011-10-26 | 693861 | View Edit Delete | |||||||||||
| 626788 | 38403 | GLUCOSA FRESENIUS KABI 20% SOLUCIÓN PARA PERFUSIÓN | GLUCOSA FRESENIUS KABI 20% SOLUCIÓN PARA PERFUSIÓN , 12 frascos de 500 ml | 20% | 6 | 12 | 48 | 12 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/38403/38403_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/38403/38403_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1962-11-01 | 1 | 1 | 1 | 1962-11-01 | 2001-01-17 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 628339 | 63629 | KABIPAC RINGER LACTATO SOLUCION PARA PERFUSION | KABIPAC RINGER LACTATO SOLUCION PARA PERFUSION , 10 frascos de 500 ml | 6 mg/ml + 0,4 mg/ml + 0,27 mg/ml + 3,17 mg/ml inyectable 500 ml | 6 | 10 | 48 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63629/63629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63629/63629_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2001-01-26 | 1 | 1 | 1 | 2001-01-26 | 2001-06-21 | 1 | 2013-10-14 | View Edit Delete | ||||||||||||
| 628347 | 63629 | KABIPAC RINGER LACTATO SOLUCION PARA PERFUSION | KABIPAC RINGER LACTATO SOLUCION PARA PERFUSION , 10 frascos de 1.000 ml | 6 mg/ml + 0,4 mg/ml + 0,27 mg/ml + 3,17 mg/ml inyectable 1.000 ml | 6 | 10 | 48 | 10 frascos de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63629/63629_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63629/63629_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2001-01-26 | 1 | 1 | 1 | 2001-01-26 | 2001-06-21 | 1 | 2016-07-22 | View Edit Delete |
Page 59 of 1036, showing 20 records out of 20709 total, starting on record 1161, ending on 1180